Chemed (CHE) Projected to Post Quarterly Earnings on Wednesday

Chemed (NYSE:CHEGet Free Report) will likely be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $7.02 per share and revenue of $659.0860 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:00 AM ET.

Chemed Stock Performance

Shares of CHE opened at $472.95 on Wednesday. The company has a 50 day moving average price of $442.13 and a 200-day moving average price of $442.72. Chemed has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The stock has a market capitalization of $6.70 billion, a PE ratio of 25.01, a PEG ratio of 2.30 and a beta of 0.44.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be issued a dividend of $0.60 per share. The ex-dividend date is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio is currently 12.69%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 3.29% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in CHE. Aster Capital Management DIFC Ltd acquired a new stake in shares of Chemed in the fourth quarter worth $191,000. McMillan Office Inc. purchased a new stake in Chemed in the fourth quarter valued at $171,000. Parallel Advisors LLC boosted its holdings in Chemed by 34.0% in the fourth quarter. Parallel Advisors LLC now owns 406 shares of the company’s stock valued at $174,000 after purchasing an additional 103 shares during the last quarter. Quarry LP grew its position in Chemed by 57.1% during the 3rd quarter. Quarry LP now owns 385 shares of the company’s stock worth $172,000 after purchasing an additional 140 shares during the period. Finally, Cresset Asset Management LLC purchased a new position in shares of Chemed during the 3rd quarter valued at about $204,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CHE shares. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada reduced their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $555.50.

View Our Latest Stock Report on Chemed

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Earnings History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.